logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11642413 B1

PDFFull Text
Date of Patent:
May. 09, 2023

Filed:

Mar. 04, 2022

Compounds for degrading tau protein aggregates and uses thereof

Applicant:

Aprinoia Therapeutics Limited, Wanchai, CN;

Inventors:

Paul Tempest, Taipei, TW;

Ming-Kuei Jang, Taipei, TW;

Yih-Shyan Lin, Kaohsiung, TW;

Assignee:

APRINOIA THERAPEUTICS LIMITED, Hong Kong, CN;

Attorney:

Foley & Lardner LLP

Primary Examiner:

Samira J Jean-Louis

Int. Cl.
CPC ...
C07D 417/14 (2006.01); C07D 471/04 (2006.01); A61K 47/55 (2017.01); A61P 25/28 (2006.01); A61K 31/427 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/506 (2006.01); C07D 413/14 (2006.01); A61K 47/54 (2017.01); A61K 31/444 (2006.01);
U.S. Cl.
CPC ...
A61K 47/55 (2017.08); A61K 31/427 (2013.01); A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/506 (2013.01); A61K 47/54 (2017.08); A61K 47/545 (2017.08); A61P 25/28 (2018.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract

Disclosed herein are novel compounds for degrading Tau protein aggregates, pharmaceutical acceptable salts, enantiomers, non-enantiomers, tautomers, racemates, solvates, metabolic precursors, or prodrugs thereof. Also disclosed herein are uses of the compounds, pharmaceutical acceptable salts, enantiomers, non-enantiomers, tautomers, racemates, solvates, metabolic precursors, or prodrugs thereof in manufacture a medicament for treating a tauopathy, as well as method for aiding in the treatment of a tauopathy or treating a tauopathy in a subject.

Find Patent Forward Citations

Tempest, Paul. (2023). Compounds for degrading tau protein aggregates and uses thereof (U.S. Patent No. 11642413). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11642413

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…